US halts University of Oklahoma clinical researchBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7255.195 (Published 22 July 2000) Cite this as: BMJ 2000;321:195
- Fred Charatan
A new federal agency in the United States, established to protect the interests of patients who are the subjects of research, has shut down all government sponsored clinical trials at the University of Oklahoma Health Sciences Center at Tulsa, Oklahoma.
Michael Carome, chief compliance officer of the federal Office for Human Research Protections of the US Department of Health and Human Services, has been sharply critical of Dr Michael McGee, vice chairman of the department of surgery and principal researcher.
He also criticised the institutional review board of the university for failing to exercise meaningful oversight …